Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Lamothe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|April 14, 2022
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular DystrophyCedric Happi Mbakam, Gabriel Lamothe, Jacques P Tremblay
Molecular Therapy. Nucleic Acids|October 16, 2023
CRISPR-Cas9 delivery strategies with engineered extracellular vesiclesYaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
Plos One|December 28, 2020
The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cellsAntoine Guyon, Joël Rousseau, Gabriel Lamothe, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 15, 2022
CRISPR-Cas9 Gene Therapy for Duchenne Muscular DystrophyCedric Happi Mbakam, Gabriel Lamothe, Guillaume Tremblay, et al.
Molecular Therapy. Nucleic Acids|April 5, 2021
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD <i>in vitro</i>Antoine Guyon, Joël Rousseau, Francis-Gabriel Bégin, et al.
International Journal of Molecular Sciences|June 26, 2025
In Vitro Correction of Point Mutations in the <i>DYSF</i> Gene Using Prime EditingCamille Bouchard, Joël Rousseau, Gabriel Lamothe, et al.
Frontiers in Medicine|June 12, 2023
Prime editing strategies to mediate exon skipping in <i>DMD</i> geneCedric Happi Mbakam, Jeanne Roustant, Joel Rousseau, et al.
The CRISPR Journal|June 22, 2023
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13Gabriel Lamothe, Julie Carbonneau, Charles Joly Beauparlant, et al.
International Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|April 14, 2022
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular DystrophyCedric Happi Mbakam, Gabriel Lamothe, Jacques P Tremblay
Molecular Therapy. Nucleic Acids|October 16, 2023
CRISPR-Cas9 delivery strategies with engineered extracellular vesiclesYaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
Plos One|December 28, 2020
The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cellsAntoine Guyon, Joël Rousseau, Gabriel Lamothe, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 15, 2022
CRISPR-Cas9 Gene Therapy for Duchenne Muscular DystrophyCedric Happi Mbakam, Gabriel Lamothe, Guillaume Tremblay, et al.
Molecular Therapy. Nucleic Acids|April 5, 2021
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD <i>in vitro</i>Antoine Guyon, Joël Rousseau, Francis-Gabriel Bégin, et al.
International Journal of Molecular Sciences|June 26, 2025
In Vitro Correction of Point Mutations in the <i>DYSF</i> Gene Using Prime EditingCamille Bouchard, Joël Rousseau, Gabriel Lamothe, et al.
Frontiers in Medicine|June 12, 2023
Prime editing strategies to mediate exon skipping in <i>DMD</i> geneCedric Happi Mbakam, Jeanne Roustant, Joel Rousseau, et al.
The CRISPR Journal|June 22, 2023
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas13Gabriel Lamothe, Julie Carbonneau, Charles Joly Beauparlant, et al.
International Journal of Molecular Sciences|April 17, 2025
Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 ChannelKelly Godbout, Mathieu Dugas, Steven R Reiken, et al.
Pageof 1